VistaGen Therapeutics Inc (VTGN) valuation · rev $1.3M
VistaGen Therapeutics Inc (VTGN) rev $1.3M.
| Metric | Value |
|---|---|
| Market cap | $28.1M |
| Revenue | $1.3M |
| P/S | 22.2 |
| P/B | 0.8 |
VTGN valuation FAQ
What is VTGN's market cap?
VistaGen Therapeutics Inc (VTGN) market cap is $28.1M on the latest cached fundamentals snapshot.
What is VTGN's latest revenue?
Latest cached VistaGen Therapeutics Inc (VTGN) revenue was $1.3M. Statements: https://lician.com/financials/vtgn
What is VTGN's price-to-sales ratio?
VistaGen Therapeutics Inc (VTGN) price-to-sales (P/S) is 22.2, cached market cap $28.1M divided by revenue $1.3M.
What is VTGN's price-to-book ratio?
VistaGen Therapeutics Inc (VTGN) price-to-book (P/B) is 0.8 on the latest cached fundamentals snapshot.
How many VTGN valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for VistaGen Therapeutics Inc (VTGN): Market cap, Revenue, P/S, and P/B.
Where is VTGN valuation listed?
Cached valuation multiples for VistaGen Therapeutics Inc (VTGN) are listed at https://lician.com/valuation/vtgn.
Not investment advice. Cached rows, not a live tape.